KCK LTD.

In its 13F for Q2 2025 (holdings as of June 30, 2025, filed July 8, 2025), KCK LTD. reported 2 stock positions worth $18.3 million. Its top holding was Sight Sciences (SGHT) at 98.6% of the portfolio, followed by Rein Therapeutics (RNTX, 1.4%). Its holdings were unchanged from Q1 2025.

Most Recent 13F
Q3 2025
Location
HAMILTON, D0
CIK
0001657662
Portfolio Value
$18.3M (Q2 2025)
SEC Filing
0001657662-25-000012 ↗ filed Jul 8, 2025

Holdings Value

0$20.0M$40.0M$60.0M$80.0M Q4 2024: $75.0M Q4 2024 Q1 2025: $10.5M Q1 2025 Q2 2025: $18.3M $18.3M Q2 2025 Q3 2025: $15.1M Q3 2025

Holdings 2 stocks · $18.3M
SGHT Sight Sciences Inc. 98.64% 4,374,975 $18.1M No change
RNTX Rein Therapeutics Inc. 1.36% 22,341 $249K No change

Portfolio Sells Q1 2025 → Q2 2025
None this quarter.

Portfolio Buys Q1 2025 → Q2 2025
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q3 2025 2$15.1MSGHT, RNTX
Q2 2025 2$18.3MSGHT, RNTX
Q1 2025 2$10.5MSGHT, RNTX
Q4 2024 3$75.0MNPCE, SGHT, RNTX